EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis

Li Xie, Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Chang Liu, Yu-Li Wang, Ya-Jun Yan, Jia Ding, Xiao Teng, Qiang Yang und 2 weitere

Clinical and Molecular Hepatology · 01.04.2024 · 30 (2) · 206-224

DOI: 10.3350/cmh.2023.0506 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.04.2024. Verfasst von Li Xie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology & Parasitology, MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Cholestasis, Liver Neoplasms, Cell Adhesion Molecules. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Shanghai Commission of Sciences and Technologies, National Key R/D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Cholestatic liver diseases including primary biliary cholangitis (PBC) are associated with active hepatic fibrogenesis, which ultimately progresses to cirrhosis. Activated hepatic stellate cells (HSCs) are the main fibrogenic effectors in response to cholangiocyte damage. JCAD regulates cell proliferation and malignant transformation in nonalcoholic steatoheaptitis-associated hepatocellular carcinoma (NASH-HCC). However, its participation in cholestatic fibrosis has not been explored yet.

Methods

Serial sections of liver tissue of PBC patients were stained with immunofluorescence. Hepatic fibrosis was induced by bile duct ligation (BDL) in wild-type (WT), global JCAD knockout mice (JCAD-KO) and HSC-specific JCAD knockout mice (HSC-JCAD-KO), and evaluated by histopathology and biochemical tests. In situ-activated HSCs isolated from BDL mice were used to determine effects of JCAD on HSC activation.

Results

In consistence with staining of liver sections from PBC patients, immunofluorescent staining revealed that JCAD expression was identified in smooth muscle α-actin (α-SMA)-positive fibroblast-like cells and was significantly up-regulated in WT mice with BDL. JCAD deficiency remarkably ameliorated BDL-induced hepatic injury and fibrosis, as documented by liver hydroxyproline content, when compared to WT mice with BDL. Histopathologically, collagen deposition was dramatically reduced in both JCAD-KO and HSC-JCAD-KO mice compared to WT mice, as visualized by Trichrome staining and semi-quantitative scores. Moreover, JCAD deprivation significantly attenuated in situ HSC activation and reduced expression of fibrotic genes after BDL.

Conclusions

JCAD deficiency effectively suppressed hepatic fibrosis induced by BDL in mice, and the underlying mechanisms are largely through suppressed Hippo-YAP signaling activity in HSCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularCholestasisLiver NeoplasmsCell Adhesion MoleculesAnimalsHumansMiceHepatic Stellate CellsLiverLiver CirrhosisMice, Knockout

Stichwörter der Autor:innen

CholestasisHepatic stellate cellsHippo-YAP signalingJCADPrimary biliary cholangitis

Substanzen

JCAD protein, humanJCAD protein, mouseCell Adhesion Molecules

Autor:innen und Institutionen

  • Department of Medical Microbiology & Parasitology, MOE/NHC/CAMS Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University Shanghai Medical College, Shanghai, China.
  • Department of Pathology, Shanghai Fifth People's Hospital, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • Department of Gastroenterology, Jing'an District Central Hospital, Fudan University, Shanghai, China.
  • HistoIndex Pte Ltd, Singapore, Singapore.
  • Hangzhou Choutu Technology Co., Ltd., Hangzhou, China.
  • Department of Gastroenterology & Hepatology, Zhongshan Hospital of Fudan University, Shanghai, China.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Commission of Sciences and Technologies
  • National Key R/D Program of China
  • Natural Science Foundation of Shanghai

Zitieren

APA

Xie, L., Chen, H., Zhang, L., Ma, Y., Zhou, Y., Yang, Y. Y., Liu, C., Wang, Y. L., Yan, Y. J., Ding, J., Teng, X., Yang, Q., Liu, X. P., & Wu, J. (2024). JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis. Clinical and Molecular Hepatology, 30(2), 206-224. https://doi.org/10.3350/cmh.2023.0506

Vancouver

Xie L, Chen H, Zhang L, Ma Y, Zhou Y, Yang YY, et al. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis. Clinical and Molecular Hepatology. 2024;30(2):206-224. doi:10.3350/cmh.2023.0506

BibTeX
@article{Xie2024,
  author = {Xie, Li and Chen, Hui and Zhang, Li and Ma, Yue and Zhou, Yuan and Yang, Yong-Yu and Liu, Chang and Wang, Yu-Li and Yan, Ya-Jun and Ding, Jia and Teng, Xiao and Yang, Qiang and Liu, Xiu-Ping and Wu, Jian},
  title = {JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis},
  journal = {Clinical and Molecular Hepatology},
  year = {2024},
  volume = {30},
  number = {2},
  pages = {206--224},
  doi = {10.3350/cmh.2023.0506}
}
Kostenlos starten →